Among patients with cancer-related dermatomyositis, cancer remission and younger age were associated with dermatomyositis complete clinical response. Cancer remission is crucial for achieving complete ...

The study included patients with cutaneous dermatomyositis and those with muscle involvement. Treatment-emergent adverse events occurred in 80% and 81% of dazukibart 150 mg and 160 mg groups.